Daniel Cohen
Independent DirectorMr. Daniel Cohen serves as Venture Partner at Accelmed Partners. He joined Accelmed Partners in 2022 as a Venture Partner. He brings extensive investment experience with successful Medtech and Biotech investments over several years. Prior to joining Accelmed Partners, he founded his own investment consulting company conducting, on behalf of major funds (including Accelmed, Johnson & Johnson Development Corporation, Orbimed, Pontifax, BRM, Peregrine, Alive, aMoon, Milestone…), the analysis & execution of more than 40 investment opportunities in the healthcare industry and in medical devices. Prior to that, he was the General Manager of Fosun Pharma in Israel where he was involved in large transactions including Alma Lasers (HKSE 1696.HK), Kite Pharma (acquired by Gilead), TytoCare & CheckCap (NASDAQ:CHEK). He serves as Director at Minerva Surgical, Inc. since February 2023. He served as Venture Partner at Jerusalem Venture Partners since joining the firm in March 2021. In the past, he has advised hundreds of companies in these industries, including investments of hundreds of millions of dollars. He began his career in PE & Venture Capital at Credit Agricole Private Equity supporting both fund of funds and direct investment in Israel. Mr. Cohen has a B.Sc in Computer Engineering and Applied Mathematics and an MBA from ESSEC Business School in Paris.
Positions
- Company NameMinerva Surgical, Inc.Stock CodeUTRSPositionIndependent Director
